Literature DB >> 23834278

Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration.

Rodrigo D Tosso1, Sebastian A Andujar, Lucas Gutierrez, Emilio Angelina, Ricaurte Rodríguez, Manuel Nogueras, Héctor Baldoni, Fernando D Suvire, Justo Cobo, Ricardo D Enriz.   

Abstract

A molecular modeling study on dihydrofolate reductase (DHFR) inhibitors was carried out. By combining molecular dynamics simulations with semiempirical (PM6), ab initio, and density functional theory (DFT) calculations, a simple and generally applicable procedure to evaluate the binding energies of DHFR inhibitors interacting with the human enzyme is reported here, providing a clear picture of the binding interactions of these ligands from both structural and energetic viewpoints. A reduced model for the binding pocket was used. This approach allows us to perform more accurate quantum mechanical calculations as well as to obtain a detailed electronic analysis using the quantum theory of atoms in molecules (QTAIM) technique. Thus, molecular aspects of the binding interactions between inhibitors and the DHFR are discussed in detail. A significant correlation between binding energies obtained from DFT calculations and experimental IC₅₀ values was obtained, predicting with an acceptable qualitative accuracy the potential inhibitor effect of nonsynthesized compounds. Such correlation was experimentally corroborated synthesizing and testing two new inhibitors reported in this paper.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23834278     DOI: 10.1021/ci400178h

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  11 in total

1.  Insight into the molecular mechanism about lowered dihydrofolate binding affinity to dihydrofolate reductase-like 1 (DHFRL1).

Authors:  Jian Gao; Wei Cui; Yuguo Du; Mingjuan Ji
Journal:  J Mol Model       Date:  2013-10-12       Impact factor: 1.810

2.  An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors.

Authors:  Marcela Vettorazzi; Emilio Angelina; Santiago Lima; Tomas Gonec; Jan Otevrel; Pavlina Marvanova; Tereza Padrtova; Petr Mokry; Pavel Bobal; Lina M Acosta; Alirio Palma; Justo Cobo; Janette Bobalova; Jozef Csollei; Ivan Malik; Sergio Alvarez; Sarah Spiegel; Josef Jampilek; Ricardo D Enriz
Journal:  Eur J Med Chem       Date:  2017-08-10       Impact factor: 6.514

3.  Theoretical models to predict the inhibitory effect of ligands of sphingosine kinase 1 using QTAIM calculations and hydrogen bond dynamic propensity analysis.

Authors:  Marcela Vettorazzi; Cintia Menéndez; Lucas Gutiérrez; Sebastián Andujar; Gustavo Appignanesi; Ricardo D Enriz
Journal:  J Comput Aided Mol Des       Date:  2018-07-03       Impact factor: 3.686

4.  Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines.

Authors:  Bo Chao; Bingbing X Li; Xiangshu Xiao
Journal:  Bioorg Med Chem Lett       Date:  2017-05-16       Impact factor: 2.823

5.  Tetrahydroisoquinolines functionalized with carbamates as selective ligands of D2 dopamine receptor.

Authors:  Oscar Parravicini; M Lucrecia Bogado; Sebastián Rojas; Emilio L Angelina; Sebastián A Andujar; Lucas J Gutierrez; Nuria Cabedo; M Jesús Sanz; M Pilar López-Gresa; Diego Cortes; Ricardo D Enriz
Journal:  J Mol Model       Date:  2017-09-02       Impact factor: 1.810

6.  The Eighth Central European Conference "Chemistry towards Biology": Snapshot.

Authors:  András Perczel; Atanas G Atanasov; Vladimír Sklenář; Jiří Nováček; Veronika Papoušková; Pavel Kadeřávek; Lukáš Žídek; Henryk Kozłowski; Joanna Wątły; Aleksandra Hecel; Paulina Kołkowska; Jaroslav Koča; Radka Svobodová-Vařeková; Lukáš Pravda; David Sehnal; Vladimír Horský; Stanislav Geidl; Ricardo D Enriz; Pavel Matějka; Adéla Jeništová; Marcela Dendisová; Alžběta Kokaislová; Volkmar Weissig; Mark Olsen; Aidan Coffey; Jude Ajuebor; Ruth Keary; Marta Sanz-Gaitero; Mark J van Raaij; Olivia McAuliffe; Birgit Waltenberger; Andrei Mocan; Karel Šmejkal; Elke H Heiss; Marc Diederich; Robert Musioł; Janez Košmrlj; Jarosław Polański; Josef Jampílek
Journal:  Molecules       Date:  2016-10-17       Impact factor: 4.411

Review 7.  Quantum mechanics implementation in drug-design workflows: does it really help?

Authors:  Olayide A Arodola; Mahmoud Es Soliman
Journal:  Drug Des Devel Ther       Date:  2017-08-31       Impact factor: 4.162

8.  Synthesis, Analysis, Cholinesterase-Inhibiting Activity and Molecular Modelling Studies of 3-(Dialkylamino)-2-hydroxypropyl 4-[(Alkoxy-carbonyl)amino]benzoates and Their Quaternary Ammonium Salts.

Authors:  Tereza Padrtova; Pavlina Marvanova; Klara Odehnalova; Renata Kubinova; Oscar Parravicini; Adriana Garro; Ricardo D Enriz; Otakar Humpa; Michal Oravec; Petr Mokry
Journal:  Molecules       Date:  2017-11-23       Impact factor: 4.411

9.  Combining Charge Density Analysis with Machine Learning Tools To Investigate the Cruzain Inhibition Mechanism.

Authors:  Adriano M Luchi; Roxana N Villafañe; J Leonardo Gómez Chávez; M Lucrecia Bogado; Emilio L Angelina; Nelida M Peruchena
Journal:  ACS Omega       Date:  2019-11-12

10.  Arylaminopropanone Derivatives as Potential Cholinesterase Inhibitors: Synthesis, Docking Study and Biological Evaluation.

Authors:  Anna Hudcová; Aleš Kroutil; Renata Kubínová; Adriana D Garro; Lucas J Gutierrez; Daniel Enriz; Michal Oravec; Jozef Csöllei
Journal:  Molecules       Date:  2020-04-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.